Investment
Features
FeesSafety
Academy
More
Pluang+

Compare NiSource Inc Common Stock (NI) vs Vir Biotechnology Inc. Common Stock (VIR) Price & Performance

NiSource Inc Common StockTrade
Vir Biotechnology Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

NiSource Inc Common Stock vs Vir Biotechnology Inc. Common Stock — how do they compare? NiSource Inc Common Stock trades at $41.35 (market cap $19.79B), while Vir Biotechnology Inc. Common Stock trades at $10.2 (market cap $1.76B). The key difference: NiSource Inc Common Stock is far larger — about 11.2× Vir Biotechnology Inc. Common Stock's market cap, and NiSource Inc Common Stock pays a 2.91% dividend while Vir Biotechnology Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold NiSource Inc Common Stock for 6 Days and Vir Biotechnology Inc. Common Stock for 0 Days on average.

NIVIR
Market Cap
$19.79B$1.76B
Volume
5,778,1912,764,948
Sector
UtilitiesHealth
52-Week High
$49.08$11.78
52-Week Low
$39.00$5.12
Typical Hold Time
6 Days0 Days
Enterprise Value
$37.12B$1.32B
Dividend Yield
2.91%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

NiSource Inc Common Stock

NiSource (NI) trades at $41.49, up 0.63% today, with a bullish technical signal and strong analyst support. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 results due October 28, 2026. Fundamentals show solid profitability with a 13.15% net income margin and a P/E of 22.07. Recent news highlights dividend declarations and institutional buying interest, though the stock faces headwinds from storm recovery costs and interest rate sensitivity.

The outlook remains positive given analyst consensus with a $49.57 price target and 73% buy ratings. Key opportunities include data center demand growth and regulatory support, while risks involve volatile cash flows, high debt levels, and potential earnings pressure from operational disruptions. Investors should weigh the stable dividend yield against execution risks in a rising rate environment.

Vir Biotechnology Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

NI

No sentiment data available yet.

VIR
51% Buy49% Sell
Avg holding period · 0 Days

About NiSource Inc Common Stock

NiSource is an energy holding company whose regulated subsidiaries provide natural gas and electricity services. Its business is organized around gas distribution and electric operations in the United States.

Read more on NI →

About Vir Biotechnology Inc. Common Stock

Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.

Read more on VIR →